When we say someone has a big heart, they are kind and generous, love to give and help others and bring joy to all they ...

Prescription totals for Attruby, which is locked in a closely watched commercial battle with Pfizer’s tafamidis, have more ...

A routine checkup in 2021 led to the discovery of Carter's genetic heart condition. He received a new heart just two days ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Radiation-induced cardiomyopathy has become a significant clinical challenge with the increased use of ...

Researchers at the Yale School of Medicine (YSM) have developed a new screening test that pairs AI with portable cardiac ...

Tirzepatide is just as effective in reducing cardiovascular risk driven by central adiposity as that driven by general ...

The sudden death of a UNLV football player leaves the community seeking answers while young athletes reevaluate their own health.A report from the Las Vegas Met ...

Longview Regional Medical Center has scheduled free heart screenings Saturday for area youth ages 14 to 18. The screenings ...

Gregg Stone cast doubt on its reliability in trials, while David Cohen said QoL matters to patients and should be measured.

The device has evolved from one aimed at just functional MR to a broader HF therapy. EMPOWER will provide more insights.

Many kinds of heart disease risk factors are out of your control, which include genetic or hereditary causes. Even though you ...

BridgeBio’s ATTR cardiomyopathy drug, Attruby, achieved promising sales numbers in the weeks after its FDA approval.